Volume 107, Issue 3

Search all International Journal of Hematology articles

March 2018

Including PIH Articles on Advances in immunotherapy for hematological malignancies

Filter by

Volume:

Sort by

Date published:

New to old Old to new

17 articles in this issue

Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow
Nobuhiko Kobayashi
Hiroaki Shimizu
Hiroshi Handa
Images in Hematology 17 October 2017 Pages: 257 - 259
Guest editorial: advances in immunotherapy for hematological malignancies
Norimitsu Kadowaki
Progress in Hematology 09 February 2018 Pages: 260 - 261
NK cell therapy for hematologic malignancies
Rohtesh S. Mehta
Brion Randolph
Katayoun Rezvani
Progress in Hematology 27 January 2018 Pages: 262 - 270
Cloning and expansion of antigen-specific T cells using iPS cell technology: development of “off-the-shelf” T cells for the use in allogeneic transfusion settings
Hiroshi Kawamoto
Kyoko Masuda
Takuya Maeda
Progress in Hematology 31 January 2018 Pages: 271 - 277
Immunopathogenesis and immunotherapy of multiple myeloma
Hideto Tamura
Progress in Hematology 24 January 2018 Pages: 278 - 285
Therapeutic doses of doxorubicin induce premature senescence of human mesenchymal stem cells derived from menstrual blood, bone marrow and adipose tissue
Irina Kozhukharova
Victoria Zemelko
Nikolay Nikolsky
Original Article 11 October 2017 Pages: 286 - 296
Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β⁰-thalassemia/HbE disease
Pinyaphat Khamphikham
Orapan Sripichai
Duncan R. Smith
Original Article 24 October 2017 Pages: 297 - 310
Notch1 expression is regulated at the post-transcriptional level by the 3′ untranslated region in hematopoietic stem cell development
Shinichi Mizuno
Tadafumi Iino
Koichi Akashi
Original Article 02 November 2017 Pages: 311 - 319
Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation
Mikiko Sakuragi
Satoru Hayashi
Yoshiaki Tomiyama
Original Article 12 October 2017 Pages: 320 - 326
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial
Hirohisa Nakamae
Tetsuya Fukuda
Hirohiko Shibayama
Original Article 26 October 2017 Pages: 327 - 336
MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia
Takashi Kozakai
Masahiko Takahashi
Masahiro Fujii
Original Article 17 October 2017 Pages: 337 - 344
Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion
Kodai Kuriyama
Yutaka Enomoto
Takashi Sonoki
Original Article 25 October 2017 Pages: 345 - 354
High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia
Che Ry Hong
Hyoung Jin Kang
Hyo Seop Ahn
Original Article 20 October 2017 Pages: 355 - 362
Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations
Toshimitsu Ueki
Kenichi Hoshi
Hikaru Kobayashi
Original Article 11 October 2017 Pages: 363 - 372
Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia
Takashi Ishida
Naoyuki Akagawa
Koji Miyazaki
Case Report 13 October 2017 Pages: 373 - 377
Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma
Lucy B. Cook
Aileen G. Rowan
Graham P. Taylor
Case Report 31 October 2017 Pages: 378 - 382
Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells
Jiro Kikuchi
Yoshiaki Kuroda
Yusuke Furukawa
Letter to the Editor 28 November 2017 Pages: 383 - 385

Volume 107, Issue 3

Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow

Guest editorial: advances in immunotherapy for hematological malignancies

NK cell therapy for hematologic malignancies

Cloning and expansion of antigen-specific T cells using iPS cell technology: development of “off-the-shelf” T cells for the use in allogeneic transfusion settings

Immunopathogenesis and immunotherapy of multiple myeloma

Therapeutic doses of doxorubicin induce premature senescence of human mesenchymal stem cells derived from menstrual blood, bone marrow and adipose tissue

Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β⁰-thalassemia/HbE disease

Notch1 expression is regulated at the post-transcriptional level by the 3′ untranslated region in hematopoietic stem cell development

Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial

MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia

Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion

High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia

Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations

Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia

Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma

Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells

Navigation